Labshake search
Citations for R&D Systems :
1 - 50 of 1062 citations for 5 M TOLYL FURAN 2 CARBALDEHYDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... TNFα (5 ng/m; R&D systems #210-TA-020) and IFNγ (25 IU/mL ...
-
bioRxiv - Microbiology 2021Quote: ... ULBP-2/5/6 (65903, R&D systems), Plexin-B1 (rea728 ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 ng/ml FGF-2 (R&D Systems) and 1 μM CHIR99021 (STEMCELL Technologies) ...
-
bioRxiv - Immunology 2019Quote: ... (5) IL-1β (2 ng/ml, R&D Systems), (6 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 5 ng/mL FGF-2 (R&D systems) (MSC expansion media).
-
bioRxiv - Cell Biology 2020Quote: ... PE anti-human ULBP-2/5/6 (Clone 165903, R&D Systems), FITC Mouse IgG1 κ Isotype Control (Clone MOPC-21 ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Immunology 2022Quote: ... M-CSF (R&D Systems) and ApoE (Abcam ...
-
bioRxiv - Neuroscience 2020Quote: ... The growth medium was replaced with DMEM supplemented with 2 ng/mL murine M-CSF (R&D Systems; Minneapolis, MN) and cultured in Nx for 3 or 6 days prior to LPS treatment.
-
bioRxiv - Immunology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC).
-
bioRxiv - Cell Biology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC). Fully differentiated macrophages were harvested and seeded at the required density for the subsequent experiments.
-
bioRxiv - Microbiology 2021Quote: ... and cultured in media containing IL-2 (5 ng/ml; R&D Systems), in the presence or in the absence of GGSK2691805A (5 μM) ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were cultured in osteoclast medium supplemented with 10 ng/ml of M-CSF and 5 ng/ml of murine RANKL (R&D Systems) for 7-10 days ...
-
bioRxiv - Cell Biology 2020Quote: ... Bone marrow cells were plated in four replicates in 24-well plates at a density of 5 × 104 cells/well with 10 ng/ml of M-CSF (R&D Systems). Three days later ...
-
bioRxiv - Immunology 2020Quote: ... in serum-free medium (5 x 106/4 ml of AIM-V) supplemented with M-CSF (50 ng/ml; R&D Systems) over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Neuroscience 2020Quote: Mouse myelogenous leukemia (M-NFS-60) cells were M-CSF (R&D systems, 216-MC/CF) starved for 24 hours ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Bioengineering 2023Quote: ... and further supplemented with 5 ng ml -1 of FGF-2 (R&D Systems). Medium was changed twice a week ...
-
bioRxiv - Cancer Biology 2023Quote: ... purified sheep IgG (2 mg/mL for LRIG1 R&D Systems #5-001-A), and mouse IgG1-PE conjugate (10 uL for LGR5 ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 1 ng/mL transforming growth factor beta-1 (TGF-β1) and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from R&D Systems) at 37°C and 5% CO2 in a humidified incubator (Thermo Scientific Heraeus ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Neuroscience 2021Quote: ... recombinant human M-CSF (R&D Systems), 100 μg/mL streptomycin ...
-
bioRxiv - Developmental Biology 2021Quote: ... ONCOSTATIN M (295-OM, R&D Systems), LIF (7734-LF ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-mouse Oncostatin M (R&D systems), anti-mouse IL-6 (BioxCell) ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Cancer Biology 2024Quote: ... Secondary antibody was added for ULBP 1 and 2/5/6 only (R&D Systems). Cells were then washed and fixed in 4% paraformaldehyde ...
-
bioRxiv - Molecular Biology 2021Quote: ... Samples were immuno-precipitated with 2-5 µg of either anti-GFI1 (AF3540, R&D systems), anti-H3K4me1 (ab8895 ...
-
bioRxiv - Biochemistry 2019Quote: ... M-CSF (10 ng/ml, R&D Systems), 1% penicillin-streptomycin (Gibco) ...
-
bioRxiv - Cancer Biology 2021Quote: ... mouse M-CSF (R&D systems, 416-ML), anti-mouse IFN-α neutralizing antibody (PBL Assay Science ...
-
bioRxiv - Systems Biology 2023Quote: ... and 100ng/ml M-CSF (R&D Systems). On day 4 ...
-
bioRxiv - Cell Biology 2023Quote: ... rhKGF (10 ng/m; “K”; R&D Systems), 50 nM dexamethasone (“D” ...
-
bioRxiv - Neuroscience 2024Quote: ... 25 ng/mL M-CSF (R&D System) and 50 ng/mL TGFβ1 (STEMCELL Technologies ...
-
bioRxiv - Microbiology 2024Quote: ... and 50ng/ml M-CSF (R&D Systems) to induce macrophage differentiation ...
-
bioRxiv - Developmental Biology 2024Quote: ... for 5 days followed by a further 15 days in Stage 2b media (HCM containing 10 𝜇g/mL Oncostatin M (R&D Systems Cat No. 295-OM) and 10nM dexamethasone).
-
bioRxiv - Cancer Biology 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems).
-
bioRxiv - Immunology 2021Quote: ... 40ng/ml of rm M-CSF (R&D System) and allowed to differentiate for 7 days.
-
bioRxiv - Microbiology 2022Quote: ... plus 10 ng/mL M-CSF (R&D Systems). Fully differentiated MDMs were maintained in media containing RPMI 1640 plus 10% dialyzed FBS ...
-
bioRxiv - Microbiology 2023Quote: ... and 10 ng/mL M-CSF (R&D Systems). On Day 2 and Day 4 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 20 ng/mL oncostatin M (R&D Systems, 295OM050), and 0.1 μM dexamethasone (Millipore Sigma ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 25 ng/mL M-CSF (R&D Systems) for 2 days ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... and anti-M-CSF (#AF416 from R&D Systems). Detection was performed using peroxidase-coupled secondary antibody ...
-
bioRxiv - Cell Biology 2020Quote: Mature adipocytes were cultured in complete medium supplemented with AZA (R&D Systems; 5, 10, 20µM; 2 days) and rhPDGF-AB (Miltenyi Biotec ...
-
bioRxiv - Immunology 2022Quote: ... cells were cultured in the presence of IL-2 (5 ng/ml; R&D Systems, Minneapolis, MN, USA), and in the presence or the absence of CH-223191 or FICZ ...
-
bioRxiv - Microbiology 2020Quote: ... + 50 ng/ml M-CSF (R&D Systems, https://www.rndsystems.com) and 50 ng/ml GM-CSF + 500 U/ml IL-4 (Biolegend ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... and 30ng/ml M-CSF (R&D Systems, Abingdon, UK) and incubated in T75 flasks for 24h at 37°C ...
-
bioRxiv - Cell Biology 2022Quote: ... 40 ng/mL M-CSF (R&D Systems, 416-ML). The cells were then incubated with osteoclastogenesis medium ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml M-IL4 (R&D systems, 404-ML-050) and 20ng/ml M-IL13 (R&D systems ...
-
bioRxiv - Immunology 2020Quote: ... containing 20 ng/mL M-CSF (R&D System, USA) on 10-cm petri dishes and renewed the medium every other day ...